Ventyx Biosciences Ownership | Who Owns Ventyx Biosciences?


OverviewForecastRevenueFinancialsChart

Ventyx Biosciences Ownership Summary


Ventyx Biosciences is owned by 8.60% institutional investors, 4.11% insiders, and 87.30% retail investors. Blackrock is the largest institutional shareholder, holding 7.72% of VTYX shares. American Funds SMALLCAP World A is the top mutual fund, with 7.43% of its assets in Ventyx Biosciences shares.

VTYX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockVentyx Biosciences8.60%4.11%87.30%
SectorHealthcare Stocks 42.54%10.83%46.63%
IndustryBiotech Stocks 45.22%10.75%44.04%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock4.77M7.72%$11.02M
Affinity asset advisors3.92M5.51%$12.20M
Vanguard group3.77M5.29%$11.72M
Point72 asset management3.21M4.51%$9.98M
Tang capital management3.10M4.35%$9.64M
Marshall wace, llp2.32M3.25%$7.20M
Vestal point capital, lp2.05M2.88%$6.38M
Ikarian capital1.31M1.84%$4.07M
Blackrock funding, inc. /de1.18M1.66%$3.68M
Sectoral asset management1.11M1.56%$3.44M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Sectoral asset management1.11M2.13%$3.44M
Affinity asset advisors3.92M1.06%$12.20M
Sio capital management829.18K0.65%$2.58M
Ikarian capital1.31M0.41%$4.07M
Tang capital management3.10M0.37%$9.64M
Redmile group1.07M0.32%$3.34M
Sphera funds management440.11K0.29%$1.37M
Vestal point capital, lp2.05M0.29%$6.38M
Birchview capital, lp98.83K0.23%$307.35K
683 capital management1.00M0.16%$3.11M

Top Buyers

HolderShares% AssetsChange
Blackrock4.77M0.00%1.02M
Baker bros. advisors lp1.02M0.02%1.02M
683 capital management1.00M0.16%1.00M
Vanguard group3.77M0.00%607.73K
Jacobs levy equity management475.73K0.00%475.73K

Top Sellers

HolderShares% AssetsChange
Capital investors---5.25M
Farallon capital management---3.17M
Cormorant asset management, lp---2.71M
Point72 asset management3.21M0.02%-2.69M
Octagon capital advisors lp---2.39M

New Positions

HolderShares% AssetsChangeValue
Baker bros. advisors lp1.02M0.02%1.02M$3.18M
683 capital management1.00M0.16%1.00M$3.11M
Jacobs levy equity management475.73K0.00%475.73K$1.10M
Two sigma investments, lp436.08K0.00%436.08K$1.36M
Gsa capital partners llp242.23K0.06%242.23K$753.00K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-9.00
Zurcher kantonalbank (zurich cantonalbank)-55.00
Avion wealth-63.00
Federation des caisses desjardins du quebec-120.00
Modus advisors-150.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202529-73.64%6,121,464-84.99%80.26%9-85.25%10-71.43%
Jun 30, 2025116-3.33%44,424,8000.02%621.60%609.09%4014.29%
Mar 31, 20259-92.91%8,136,748-85.06%110.19%4-94.20%3-89.66%
Dec 31, 20241211.68%53,151,2081.28%751.36%658.33%28-9.68%
Sep 30, 2024119-52,481,496-7.84%741.14%607.14%31-16.22%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
American Funds SMALLCAP World A5.25M7.43%2.89M
Vanguard Total Stock Mkt Idx Inv1.99M2.79%211.60K
Vanguard Institutional Extnd Mkt Idx Tr647.55K0.91%-225.46K
Fidelity Small Cap Index621.71K0.87%-23.02K
iShares Russell 2000 Value ETF536.88K0.75%-
MEDICAL BioHealth EUR Acc536.95K0.75%536.95K
Delaware Healthcare I430.00K0.61%-
Macquarie Healthcare I430.00K0.60%-
State St Russell Sm/Mid Cp® Indx NL Cl C419.68K0.59%-
State St Russell Sm/Mid Cp® Indx SL Cl I419.68K0.59%-

Recent Insider Transactions


DateNameRoleActivityValue
Apr 02, 2025Nuss John CHIEF SCIENTIFIC OFFICERSell$2.02K
Dec 27, 2024Nuss John CHIEF SCIENTIFIC OFFICERSell$49.84K
Dec 23, 2024Gujrathi Sheila-Buy$300.57K
Dec 19, 2024Nuss John CHIEF SCIENTIFIC OFFICERSell$29.68K
Nov 25, 2024Mohan Raju CEO AND PRESIDENTBuy$524.94K

Insider Transactions Trends


DateBuySell
2025 Q4--
2025 Q2-1
2025 Q1--
2024 Q432
2024 Q3--

VTYX Ownership FAQ


Who Owns Ventyx Biosciences?

Ventyx Biosciences shareholders are primarily institutional investors at 8.60%, followed by 4.11% insiders and 87.29% retail investors. The average institutional ownership in Ventyx Biosciences's industry, Biotech Stocks , is 45.22%, which Ventyx Biosciences falls below.

Who owns the most shares of Ventyx Biosciences?

Ventyx Biosciences’s largest shareholders are Blackrock (4.77M shares, 7.72%), Affinity asset advisors (3.92M shares, 5.51%), and Vanguard group (3.77M shares, 5.29%). Together, they hold 18.52% of Ventyx Biosciences’s total shares outstanding.

Does Blackrock own Ventyx Biosciences?

Yes, BlackRock owns 7.72% of Ventyx Biosciences, totaling 4.77M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 11.02M$. In the last quarter, BlackRock increased its holdings by 1.02M shares, a 27.34% change.

Who is Ventyx Biosciences’s biggest shareholder by percentage of total assets invested?

Sectoral asset management is Ventyx Biosciences’s biggest shareholder by percentage of total assets invested, with 2.13% of its assets in 1.11M Ventyx Biosciences shares, valued at 3.44M$.

Who is the top mutual fund holder of Ventyx Biosciences shares?

American Funds SMALLCAP World A is the top mutual fund holder of Ventyx Biosciences shares, with 7.43% of its total shares outstanding invested in 5.25M Ventyx Biosciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools